Greenstone G, Hammerberg S, Marks M I
Chemotherapy. 1978;24(1):29-33. doi: 10.1159/000237756.
A new aminoglycoside antibiotic, netilmicin, was tested against 306 clinical isolates from ill children and compared with sisomicin and gentamicin. Activity against Enterobacteriaceae was similar to that of gentamicin but less than that of sisomicin. Two gentamicin-resistant strains of Enterobacteriaceae (Klebsiella, MIC 6.25 microgram/ml, Escherichia coli, MIC 12.5 microgram/ml) were susceptible to netilimicin (MIC 3.12 microgram/ml). Netilmicin was ineffective against almost all strains of Pseudomonas but active against the majority of strains of Staphylococcus, Neisseria meningitidis and Haemophilus influenzae tested. Disc diffusion sensitivity results correlated in general with the agar dilution test. Netilmicin had little activity against Pseudomonas but may be useful in the treatment of infections due to gentamicin-resistant Enterobacteriaceae.
一种新的氨基糖苷类抗生素奈替米星,针对患病儿童的306株临床分离菌进行了测试,并与西索米星和庆大霉素进行了比较。其对肠杆菌科细菌的活性与庆大霉素相似,但低于西索米星。两株对庆大霉素耐药的肠杆菌科细菌(克雷伯菌,MIC 6.25微克/毫升,大肠杆菌,MIC 12.5微克/毫升)对奈替米星敏感(MIC 3.12微克/毫升)。奈替米星对几乎所有铜绿假单胞菌菌株均无效,但对测试的大多数葡萄球菌、脑膜炎奈瑟菌和流感嗜血杆菌菌株有活性。纸片扩散法药敏结果总体上与琼脂稀释试验相关。奈替米星对铜绿假单胞菌活性很小,但可能对治疗由耐庆大霉素的肠杆菌科细菌引起的感染有用。